查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1809935

DNA 片段市场按类型、产品类型、技术、应用和最终用户划分—全球预测，2025-2030 年

DNA Fragments Market by Type, Product Type, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年 DNA 片段市场价值将达到 21.8 亿美元，2025 年将成长至 23.5 亿美元，到 2030 年将达到 34.9 亿美元，复合年增长率为 8.17%。

主要市场统计数据
基准年2024年 21.8亿美元
预计2025年 23.5亿美元
预测年份 2030 34.9亿美元
复合年增长率（%） 8.17%

揭示DNA片段研发背后的根本驱动力：惊人的科学突破塑造了生物技术前沿

在快速发展的生物技术领域，DNA片段已成为研究人员和产业领袖的重要工具。这些短核苷酸序列构成了从基因编辑到诊断检测等无数应用的基础。随着对基因组学的科学理解不断加深，操纵和分析DNA片段的能力为探索细胞机制和疾病途径提供了前所未有的精确度。

探索将彻底改变 DNA 片段合成及其在生物技术中的应用的技术和科学模式转移

近年来，科技进步浪潮深刻地改变了DNA片段的合成、分析和应用方式。高通量定序平台如今拥有无与伦比的准确性和速度，使研究人员能够以单一碱基分辨率解析片段组成。同时，酶促和化学合成通讯协定的改进显着缩短了周转时间，促使人们从大规模生产转向高度客製化的片段库，以满足特定的研究需求。

评估 2025 年美国关税对 DNA 片段产业的深远影响，这将改变供应链和监管格局

2025年美国新关税的实施，为依赖DNA片段及相关试剂跨境贸易的组织带来了复杂的挑战。随着关键起始材料被征收进口关税，成本结构正在重新平衡，迫使供应商和最终用户重新评估供应链的弹性和营运成本。这些调整正层层递进，影响上游生产设施和下游实验室。

揭示关键的细分动态，揭示不同的 DNA 片段类型、技术、应用和使用者资料如何塑造市场机会

透过多种细分视角审视市场动态，可以对其有更细緻的理解。 DNA片段的类型可分为双链片段和单链片段，前者因其在克隆和基因组组装中的稳定性而备受推崇，而后者正越来越多地被用于靶向寡核苷酸治疗和精准基因探测。从生物来源提取的天然DNA与精确规格化学组装的合成DNA之间的区别，进一步明确了使用者偏好和应用适用性。

区域成长轨迹分析表明，美洲、欧洲、中东和非洲以及亚太地区是 DNA 片段进步的关键区域

了解区域特性对于理解DNA片段化研究在世界各地的进展至关重要。在美洲，强大的研究基础设施和大量的私人投资使该地区在商业性试剂开发和先进治疗研究方面处于领先地位。领先的学术中心和产业合作伙伴之间的合作正在推动基于片段的诊断和个人化医疗的创新。

聚焦推动 DNA 碎片化能力和合作研究突破的领先产业相关人员的策略定位和创新

DNA片段化领域的主要相关人员以其对平台整合、自动化和协作的策略重点而闻名。领先的公司正在透过有针对性的收购以及与专业试剂开发商的合作来扩展其产品组合，从而拓展其技术产品线和全球分销范围。透过投资从片段设计软体到高通量合成和品管分析的端到端解决方案，这些公司凭藉其服务的广度和可靠性脱颖而出。

制定实用的产业建议，以提高效率、推动创新并在 DNA 片段研究环境中保持竞争优势

为了在这种动态环境中取得成功，产业领导者应采取多管齐下的方法，优先考虑技术卓越性和营运敏捷性。投资自动化合成和分析平台可以显着缩短週转时间并最大限度地减少人为错误。辅以强大的品管通讯协定，可以增强客户信心并满足合规性要求。

了解整合资料收集、分析和检验技术的强大调查方法，从而深入了解全面的 DNA 片段

这项综合分析采用了一手资料和二手资料相结合的方法，以确保洞察的深度和可靠性。一手资料研究包括与顶尖研究人员、采购专家和监管专家进行的结构化访谈，他们就技术采用、供应链动态和关税影响提供了定性观点。此外，我们还对来自学术、临床和工业领域的实验室管理人员和最终用户进行了深入的问卷调查，作为这些访谈的补充。

整合关键发现和策略观点，阐明未来发展道路并推动 DNA 片段研究的持续进步

本摘要了主要发现，重点介绍了先进的合成和分析技术对 DNA 片段格局的变革性影响。 2025 年的关税变化凸显了供应链敏捷性和策略采购的重要性，而技术创新则持续推动片段製造的精准度和效率。細項分析揭示了不同类型、技术、应用和最终用户类别之间的细微偏好，为有针对性的策略发展提供了蓝图。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 按需台式 DNA 片段合成器改变了学术界和工业界的研究工作流程
  • 基因治疗市场对 GMP 级 DNA 片段的需求不断增长，推动了生产规模的扩大
  • 高通量 DNA 片段合成技术的进步提高了整个生物技术产业的成本效率
  • 整合人工智慧引导设计平台可提高客製化 DNA 片段组装的准确性
  • 酵素组装方法的出现，降低了合成 DNA 片段建构过程中的错误率
  • 不断发展的法规结构，以确保商业性DNA 片段製造的品质和安全
  • 扩展多重 DNA 片段库以实现药物研发流程中的快速筛检
  • 生技公司与学术实验室之间的策略合作，加速 DNA 片段化技术的创新

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. DNA片段市场类型

  • 双链
  • 单链

第九章 DNA 片段市场（依产品类型）

  • 天然DNA
  • 合成DNA

第 10 章 DNA 片段市场（依技术）

  • 化学合成
  • 酵素合成
  • 基于PCR的扩增

第 11 章 DNA 片段市场（依应用）

  • 生物技术
    • 生物资讯学
    • 生物技术
  • 医疗保健
    • 诊断
    • 治疗
  • 研究与开发

第 12 章 DNA 片段市场（按最终用户）

  • 学术和研究机构
  • CRO
  • 医院和诊所
  • 製药公司

13.美洲DNA片段市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 欧洲、中东和非洲的 DNA 片段市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太地区DNA片段市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • Ansa Biotechnologies, Inc.
    • Azenta Life Sciences
    • Abcam plc
    • DNA TwoPointO Inc.
    • Eurofins Scientific SE
    • Gene Universal, Inc.
    • GenScript Biotech Corporation
    • Illumina, Inc.
    • Integrated DNA Technologies, Inc. by Danaher Corporation
    • Merck KGaA
    • Meridian Bioscience, Inc.
    • Novartis AG
    • Pacific Biosciences of California, Inc.
    • QIAGEN NV
    • Synbio Technologies LLC
    • Takara Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience Corporation
    • Synbio Technologies Private Limited
    • Cell Signaling Technology, Inc..
    • Bio-Rad Laboratories, Inc.
    • SCSA Diagnostics Inc.
    • Profacgen

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-6E3B3C6D0807

The DNA Fragments Market was valued at USD 2.18 billion in 2024 and is projected to grow to USD 2.35 billion in 2025, with a CAGR of 8.17%, reaching USD 3.49 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.18 billion
Estimated Year [2025] USD 2.35 billion
Forecast Year [2030] USD 3.49 billion
CAGR (%) 8.17%

Unveiling the Fundamental Drivers of DNA Fragment Research and Development Shaping the Biotech Frontier with Impactful Scientific Breakthroughs

In the rapidly evolving landscape of biotechnology, DNA fragments have become a vital tool for researchers and industry leaders alike. These short sequences of nucleotides serve as the building blocks for a myriad of applications, ranging from gene editing to diagnostic assays. As scientific understanding of genomics deepens, the ability to manipulate and analyze discrete fragments of DNA offers unprecedented precision in exploring cellular mechanisms and disease pathways.

This executive summary delves into the core dynamics driving the prominence of DNA fragments. It highlights the convergence of advanced synthesis techniques with high-throughput analytical platforms, enabling breakthroughs that were once deemed impossible. Moreover, the intersection of computational biology and synthetic chemistry is expanding the boundaries of what can be achieved, paving the way for novel therapeutic candidates and expedited research workflows.

Throughout this introduction, emphasis is placed on the fundamental drivers that have propelled DNA fragment technology to the forefront of modern life sciences. By laying this foundation, readers will gain clarity on the interconnected factors-scientific, technological, and regulatory-that are shaping the current environment. As we transition into an exploration of transformative shifts, this section underlines the critical importance of DNA fragments as an engine for innovation across multiple sectors.

Exploring the Revolutionary Technological and Scientific Paradigm Shifts Revolutionizing DNA Fragment Synthesis Analysis and Application across Biotech Sectors

Across recent years, a wave of technological and scientific advancements has reshaped how DNA fragments are synthesized, analyzed, and applied. High-throughput sequencing platforms now offer unparalleled accuracy and speed, enabling researchers to decode fragment compositions with single-nucleotide resolution. Concurrently, improved enzymatic and chemical synthesis protocols have significantly reduced turnaround times, fueling a shift from large-scale production to highly customized fragment libraries tailored to specific research needs.

Moreover, the advent of automated liquid handling systems and integrated microfluidic devices has streamlined workflows that once demanded extensive manual intervention. These integrated solutions not only enhance reproducibility but also lower the barriers for smaller research teams to adopt cutting-edge methods. In parallel, developments in machine learning algorithms have transformed data analysis, empowering scientists to uncover hidden patterns within complex fragment datasets and predict structural or functional outcomes with increasing confidence.

Consequently, the ecosystem surrounding DNA fragments is no longer confined to traditional academic and clinical settings. Innovative start-ups and established life science firms alike are collaborating to bring multiplexed assays, novel gene therapies, and precision biomanufacturing processes to market. As these paradigm shifts continue to unfold, the interplay between technological refinements and translational research promises to unlock new frontiers in healthcare, agriculture, and environmental applications.

Assessing the Far-Reaching Consequences of 2025 United States Tariffs on DNA Fragment Industries Transforming Supply Chains and Regulatory Landscapes

The introduction of new United States tariffs in 2025 has introduced complex challenges for organizations relying on cross-border trade of DNA fragments and related reagents. Cost structures have been recalibrated as import duties are applied to critical starting materials, compelling suppliers and end-users to reassess supply chain resilience and operational expenditure. These adjustments have reverberated across upstream production facilities as well as downstream research laboratories.

In response, many stakeholders have initiated efforts to diversify procurement strategies, seeking alternative suppliers in regions with more favorable trade agreements. Manufacturers are exploring near-shoring options to mitigate tariff impacts, while logistics providers adjust routing and warehousing plans to optimize total landed costs. At the same time, regulatory compliance protocols have become more intricate as documents and certifications must align with evolving tariff classifications and customs requirements.

Despite these disruptions, the industry's adaptive capacity has been notable. Collaborative purchasing consortia have emerged as a mechanism to consolidate volumes and negotiate better terms, and some solution providers have introduced tariff-inclusive pricing models to simplify budgeting. As we examine segmentation insights, it becomes clear that the ability to navigate these tariff-related complexities will be a defining factor in maintaining competitive advantage and ensuring continuity of critical research and development initiatives.

Unraveling Key Segmentation Dynamics Illuminating How Diverse DNA Fragment Types Technologies Applications and User Profiles Shape Market Opportunities

A nuanced understanding of market dynamics emerges when examining the landscape through multiple segmentation lenses. Based on type, the field distinguishes between double-stranded fragments, prized for their stability in cloning and genome assembly, and single-stranded fragments, which are increasingly utilized in targeted oligonucleotide therapies and precise genetic probing. The distinction between natural DNA, extracted from biological sources, and synthetic DNA, chemically assembled to exact specifications, further delineates user preferences and application fit.

Technological segmentation reveals a trifurcation: chemical synthesis methods offer rapid, high-fidelity production for short to moderate fragment lengths; enzymatic synthesis leverages polymerases to extend sequences with high yields; and PCR-based amplification remains a workhorse for generating fragments of defined endpoints. Each approach carries unique cost, speed, and error-rate profiles, influencing its selection in research and applied settings.

Application-focused analysis spans biotechnology, medical, and R&D domains. In biotechnology, the integration of bioinformatics and molecular engineering is unlocking advanced functional studies, while medical contexts include diagnostics assays to detect genetic markers and therapeutic constructs for gene correction. Within research and development, academic and industry scientists employ fragments to elucidate fundamental biological mechanisms.

Finally, end-users range from academic and research institutes cultivating foundational science to contract research organizations offering specialized services, as well as hospitals, clinics, and pharmaceutical companies driving translational and commercialization efforts. Together, these segmentation insights illuminate the multifaceted drivers that shape priorities, investments, and technology adoptions across the spectrum.

Dissecting Regional Growth Trajectories Highlighting the Americas Europe Middle East Africa and Asia Pacific as Pivotal Arenas for DNA Fragment Advancements

Regional characteristics are pivotal in understanding how DNA fragment initiatives unfold across the globe. In the Americas, robust research infrastructure and significant private investment have positioned the region at the forefront of commercial reagent development and advanced therapeutic research. Collaboration between leading academic centers and industry partners drives innovation in fragment-based diagnostics and personalized medicine.

Europe, the Middle East and Africa exhibit a rich tapestry of regulatory frameworks and funding mechanisms. European nations benefit from coordinated research programs and standardized regulatory pathways that facilitate clinical trial approvals, while emerging markets within the Middle East and Africa are quickly establishing centers of excellence to address local health challenges using fragment technologies. Harmonization efforts are underway to streamline cross-border collaborations and knowledge sharing.

In the Asia-Pacific region, a blend of manufacturing scale-up and rapid adoption of novel biotechnologies underscores strong growth momentum. Countries with established life science clusters are investing heavily in capacity expansion for synthetic fragments, whereas emerging economies are focusing on building skilled talent pools and infrastructure to support diagnostic applications. Cross-regional partnerships are emerging to balance cost-effective production with regulatory alignment, creating a dynamic environment for next-generation fragment solutions.

Spotlighting the Strategic Positioning and Innovations of Leading Industry Stakeholders Driving Breakthroughs in DNA Fragment Capabilities and Collaborations

Leading stakeholders in the DNA fragment arena are distinguished by their strategic emphasis on platform integration, automation, and collaborative research. Key players have expanded their portfolios through targeted acquisitions and partnerships with specialized reagent developers, thereby broadening their technology offerings and global distribution networks. Investment in end-to-end solutions-from fragment design software to high-throughput synthesis and quality control analytics-has enabled these organizations to differentiate on service breadth and reliability.

Innovation pipelines have been bolstered by strategic alliances with academic institutions and biotech start-ups, accelerating the commercialization of novel fragment applications. Additionally, some companies are pioneering modular instrument designs that allow users to customize workflows according to project requirements, fostering both operational flexibility and scalability. In parallel, tiered pricing strategies and consumable subscription models have emerged, facilitating easier budgeting for research laboratories and clinical facilities.

As data integrity becomes increasingly critical, enterprises are implementing advanced informatics platforms to track fragment provenance, synthesis parameters, and performance metrics. This holistic approach to data management not only enhances reproducibility but also supports regulatory submissions and intellectual property protections. Collectively, these strategic moves underscore the central role that integrated service models and technological synergy play in shaping competitive positioning within the DNA fragment landscape.

Formulating Pragmatic Industry Recommendations to Boost Efficiency Drive Innovation and Maintain Competitive Edge in DNA Fragment Research Environment

To thrive in this dynamic environment, industry leaders should adopt a multifaceted approach that prioritizes both technological excellence and operational agility. Investing in automated synthesis and analysis platforms can significantly reduce turnaround times and minimize human error, enabling faster progression from concept to application. Complementing these investments with robust quality management protocols will strengthen customer confidence and support compliance requirements.

Diversifying supply chain partnerships is essential to mitigate risks associated with geopolitical shifts and trade policies. Engaging multiple suppliers across different regions will enhance resilience and ensure continuity of critical reagent availability. Concurrently, fostering open innovation through collaborative research agreements with academic centers and technology incubators can accelerate development cycles and unlock new fragment applications.

Embracing digital transformation initiatives-such as advanced data analytics, predictive modeling, and cloud-based collaboration tools-will empower organizations to optimize resource allocation and derive deeper insights from fragment performance data. Finally, dedicating resources to sustainability practices, including green chemistry synthesis and waste reduction, will align operations with emerging environmental standards and support long-term societal responsibility.

Detailing a Robust Research Methodology Integrating Data Collection Analysis and Validation Techniques Underpinning Comprehensive DNA Fragment Insights

This comprehensive analysis draws upon a blend of primary and secondary research methodologies to ensure depth and reliability of insights. Primary sources include structured interviews with leading researchers, procurement specialists, and regulatory experts who provided qualitative perspectives on technology adoption, supply chain dynamics, and tariff impacts. These conversations were supplemented by detailed questionnaire surveys targeting laboratory managers and end-users across academic, clinical, and industrial segments.

Secondary sources encompass peer-reviewed scientific literature, patent filings, regulatory agency publications, and publicly available corporate disclosures. Advanced text-mining techniques were applied to distill trends from large volumes of technical documents, while bespoke data-validation protocols ensured consistency and accuracy. Expert panels convened at multiple stages to review findings, challenge assumptions, and refine segment definitions.

Quantitative data points were cross-verified with industry benchmarks and historical performance indicators to confirm their relevance. The resulting dataset was synthesized through a structured framework that mapped technological capabilities, cost factors, and regulatory considerations against segment-specific priorities. This rigorous methodological approach underpins the robustness and actionable nature of the insights presented throughout the report.

Synthesizing Critical Findings and Strategic Perspectives to Illuminate Future Pathways and Catalyze Continued Advancement in DNA Fragment Research

Bringing together the critical findings, this summary underscores the transformative impact of advanced synthesis and analytical technologies on the DNA fragment landscape. The 2025 tariff changes have highlighted the importance of supply chain agility and strategic sourcing, while technological innovations continue to drive precision and efficiency in fragment production. Segmentation analysis reveals nuanced preferences across types, technologies, applications, and end-user categories, providing a roadmap for targeted strategy development.

Regional insights illustrate distinct growth trajectories, with the Americas leading in commercial reagent development, Europe, the Middle East and Africa fostering collaborative regulatory environments, and the Asia-Pacific region scaling manufacturing capabilities. Strategic actions by industry stakeholders-from platform integration to data management-emphasize the value of comprehensive service models and digital infrastructure.

Moving forward, companies that invest in automation, diversify procurement, and embrace open innovation will be well-positioned to capitalize on emerging opportunities. The methodological rigor applied in this analysis ensures that decision-makers can rely on these insights to guide investments and shape research priorities. Ultimately, this report serves as a catalyst for continued advancement, offering a clear vision of how DNA fragments will drive the next generation of biotechnological breakthroughs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rise of on-demand benchtop DNA fragment synthesizers transforming academic and industrial research workflows
  • 5.2. Growing demand for GMP-grade DNA fragments in gene therapy market fueling scale-up of production
  • 5.3. Advancements in high-throughput DNA fragment synthesis driving cost efficiencies across biotech industry
  • 5.4. Integration of AI-guided design platforms accelerating precision in custom DNA fragment assembly
  • 5.5. Emergence of enzymatic assembly methods reducing error rates in synthetic DNA fragment construction
  • 5.6. Regulatory frameworks evolving to ensure quality and safety in commercial DNA fragment manufacturing
  • 5.7. Expansion of multiplexed DNA fragment libraries enabling rapid screening in drug discovery pipelines
  • 5.8. Strategic collaborations between biotech firms and academic labs enhancing innovation in DNA fragment technologies

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. DNA Fragments Market, by Type

  • 8.1. Introduction
  • 8.2. Double-Stranded
  • 8.3. Single-Stranded

9. DNA Fragments Market, by Product Type

  • 9.1. Introduction
  • 9.2. Natural DNA
  • 9.3. Synthetic DNA

10. DNA Fragments Market, by Technology

  • 10.1. Introduction
  • 10.2. Chemical Synthesis
  • 10.3. Enzymatic Synthesis
  • 10.4. PCR Based Amplification

11. DNA Fragments Market, by Application

  • 11.1. Introduction
  • 11.2. Biotechnology
    • 11.2.1. Bioinformatics
    • 11.2.2. Biotechnology
  • 11.3. Medical
    • 11.3.1. Diagnostics
    • 11.3.2. Therapeutics
  • 11.4. Research & Development

12. DNA Fragments Market, by End-User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals & Clinics
  • 12.5. Pharmaceutical Companies

13. Americas DNA Fragments Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa DNA Fragments Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific DNA Fragments Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. Agilent Technologies, Inc.
    • 16.3.3. Ansa Biotechnologies, Inc.
    • 16.3.4. Azenta Life Sciences
    • 16.3.5. Abcam plc
    • 16.3.6. DNA TwoPointO Inc.
    • 16.3.7. Eurofins Scientific SE
    • 16.3.8. Gene Universal, Inc.
    • 16.3.9. GenScript Biotech Corporation
    • 16.3.10. Illumina, Inc.
    • 16.3.11. Integrated DNA Technologies, Inc. by Danaher Corporation
    • 16.3.12. Merck KGaA
    • 16.3.13. Meridian Bioscience, Inc.
    • 16.3.14. Novartis AG
    • 16.3.15. Pacific Biosciences of California, Inc.
    • 16.3.16. QIAGEN N.V
    • 16.3.17. Synbio Technologies LLC
    • 16.3.18. Takara Co., Ltd.
    • 16.3.19. Thermo Fisher Scientific Inc.
    • 16.3.20. Twist Bioscience Corporation
    • 16.3.21. Synbio Technologies Private Limited
    • 16.3.22. Cell Signaling Technology, Inc..
    • 16.3.23. Bio-Rad Laboratories, Inc.
    • 16.3.24. SCSA Diagnostics Inc.
    • 16.3.25. Profacgen

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. DNA FRAGMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. DNA FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. DNA FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. DNA FRAGMENTS MARKET: RESEARCHAI
  • FIGURE 26. DNA FRAGMENTS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. DNA FRAGMENTS MARKET: RESEARCHCONTACTS
  • FIGURE 28. DNA FRAGMENTS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. DNA FRAGMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DNA FRAGMENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DNA FRAGMENTS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DNA FRAGMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DOUBLE-STRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DOUBLE-STRANDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SINGLE-STRANDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SINGLE-STRANDED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL DNA FRAGMENTS MARKET SIZE, BY NATURAL DNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DNA FRAGMENTS MARKET SIZE, BY NATURAL DNA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DNA FRAGMENTS MARKET SIZE, BY SYNTHETIC DNA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PCR BASED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PCR BASED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DNA FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL DNA FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DNA FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL DNA FRAGMENTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DNA FRAGMENTS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DNA FRAGMENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DNA FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL DNA FRAGMENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DNA FRAGMENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DNA FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES DNA FRAGMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 103. CANADA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 104. CANADA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 113. MEXICO DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. MEXICO DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 115. MEXICO DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 116. MEXICO DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 117. MEXICO DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 118. MEXICO DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 125. BRAZIL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. BRAZIL DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 127. BRAZIL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 128. BRAZIL DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 129. BRAZIL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 130. BRAZIL DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 131. BRAZIL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 132. BRAZIL DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 139. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 143. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 144. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 145. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 146. ARGENTINA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA DNA FRAGMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED KINGDOM DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 177. GERMANY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. GERMANY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. GERMANY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. GERMANY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. GERMANY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. GERMANY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. GERMANY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. GERMANY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 185. GERMANY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. GERMANY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 187. GERMANY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 188. GERMANY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 189. GERMANY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 190. GERMANY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 191. FRANCE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. FRANCE DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. FRANCE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. FRANCE DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. FRANCE DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. FRANCE DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 197. FRANCE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. FRANCE DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. FRANCE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. FRANCE DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 201. FRANCE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 202. FRANCE DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 203. FRANCE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 204. FRANCE DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 205. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 207. RUSSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. RUSSIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. RUSSIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 211. RUSSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. RUSSIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. RUSSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. RUSSIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 215. RUSSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 216. RUSSIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 217. RUSSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 218. RUSSIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 219. ITALY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ITALY DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. ITALY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. ITALY DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. ITALY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. ITALY DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 225. ITALY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ITALY DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 227. ITALY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. ITALY DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 229. ITALY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 230. ITALY DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 231. ITALY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 232. ITALY DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 233. SPAIN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. SPAIN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. SPAIN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. SPAIN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. SPAIN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. SPAIN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 239. SPAIN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 241. SPAIN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. SPAIN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 244. SPAIN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 245. SPAIN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. SPAIN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED ARAB EMIRATES DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 261. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 272. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 274. SAUDI ARABIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 286. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 288. SOUTH AFRICA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 289. DENMARK DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. DENMARK DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. DENMARK DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. DENMARK DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 293. DENMARK DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. DENMARK DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 295. DENMARK DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. DENMARK DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 297. DENMARK DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. DENMARK DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 299. DENMARK DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 300. DENMARK DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 301. DENMARK DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 302. DENMARK DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 303. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 305. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 309. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 314. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 315. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 316. NETHERLANDS DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 317. QATAR DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. QATAR DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. QATAR DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. QATAR DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 321. QATAR DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 322. QATAR DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 323. QATAR DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. QATAR DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. QATAR DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 326. QATAR DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 327. QATAR DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 328. QATAR DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 329. QATAR DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 330. QATAR DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 331. FINLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. FINLAND DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 333. FINLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. FINLAND DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 335. FINLAND DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 336. FINLAND DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 337. FINLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. FINLAND DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 339. FINLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. FINLAND DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 341. FINLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 342. FINLAND DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 343. FINLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 344. FINLAND DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 345. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 347. SWEDEN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. SWEDEN DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 349. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 350. SWEDEN DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 351. SWEDEN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. SWEDEN DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 353. SWEDEN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 354. SWEDEN DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 355. SWEDEN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 356. SWEDEN DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 357. SWEDEN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 358. SWEDEN DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 359. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 360. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 361. NIGERIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. NIGERIA DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 363. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 364. NIGERIA DNA FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 365. NIGERIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 366. NIGERIA DNA FRAGMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 367. NIGERIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 368. NIGERIA DNA FRAGMENTS MARKET SIZE, BY BIOTECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 369. NIGERIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2018-2024 (USD MILLION)
  • TABLE 370. NIGERIA DNA FRAGMENTS MARKET SIZE, BY MEDICAL, 2025-2030 (USD MILLION)
  • TABLE 371. NIGERIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 372. NIGERIA DNA FRAGMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 373. EGYPT DNA FRAGMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 374. EGYPT DNA FRAGMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 375. EGYPT DNA FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-20